跳至主要内容
临床试验/NCT02703844
NCT02703844已完成不适用

Caloric Vestibular Stimulation in Parkinson's Disease

University of Kent2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
2
主要终点
Change From Baseline in the Nonmotor Symptom Severity Scale (NMSS)

研究概览

简要总结

The purpose of this study is to determine whether caloric vestibular stimulation improves symptoms of Parkinson's Disease.

详细描述

Parkinson's Disease (PD) is a nationwide public health problem, inflicting a complex constellation of physical and neuropsychiatric symptoms which are shown to progress with time. This research will investigate the potential of caloric vestibular stimulation (CVS), a non-invasive form of brain stimulation, as a treatment for individuals who suffer from Parkinson's Disease. Investigators will investigate whether core cognitive and physiological deficits are responsive to stimulation by comparing participants' performance on behavioral and physiological measures after baseline and either active or placebo stimulation phases with the aim of drawing initial insights into the application of CVS within this population. The study design is based on a single-case study that recently demonstrated durable, clinically meaningful gains in the motor and nonmotor symptoms of PD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be diagnosed with idiopathic Parkinson's Disease as defined by the UK PDS Brain Bank Criteria.
  • Participants must report limitations to Activities of Daily Life (ADL, UPDRS subscale 2)
  • Capacity to consent to the study
  • Motivated to comply with the protocol
  • An understanding of English sufficient to comply with the protocol
  • Spouse/ carer willing to support the participant throughout the study

排除标准

  • Diagnosis of induced Parkinson's or essential/dystonic tremor
  • Premorbid psychiatric history (including affective disorder, psychosis or deliberate self- harm)
  • Previous exposure to neurostimulation
  • Inner ear pathology

结局指标

主要结局

Change From Baseline in the Nonmotor Symptom Severity Scale (NMSS)

时间窗: Change at end of treatment (week 12) relative to the average of two baseline visits

The NMSS is a 30-item rater-based scale to assess a wide range of non-motor symptoms in patients with Parkinson's disease (PD). The NMSS measures the severity and frequency of non-motor symptoms across nine dimensions. Score range of 0-360, with 0 being no symptom burden

次要结局

  • Change From Baseline in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III: Motor Examination(Change at end of treatment (week 12) relative to baseline average)
  • Change From Baseline in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II: Motor Aspects of Experiences of Daily Living(Change at end of treatment (week 12) relative to baseline average)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验